Containing Or Obtained From Camellia (e.g., Tea, Including Green Or Black Tea, Etc.) Patents (Class 424/729)
  • Patent number: 8986755
    Abstract: An organic skin moisturizer, which extends and improves the skin cells life cycle, comprised of Sea Buckthorn seed oil, Camellia seed oil, Argan seed oil, Pomegranate seed oil, Meadowfoam seed oil, d-alpha tocopherol, Lecithin oil, Rosemary essential oil, Tea Tree oil, Helichrysum oil, and Coffee Arabica oil. The oils are blended together resulting in a compound that is easily applied to the skin for superior results to keep the skin cells healthier longer. This compound was created to address the Hayflick limit, which is that all skin cells can only divide a specific number of times before the skin cell dies.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: March 24, 2015
    Inventor: Sherry May Raymond-Coblantz
  • Patent number: 8974848
    Abstract: Tooth stain resulting from exposure to coloring agents contained in food and beverages, generally termed foodstuffs, is reduced, prevented and/or reversed by the addition of consumable anti-staining materials to the foodstuff anytime prior to ingestion. The anti-staining materials may be introduced into the foodstuff during the manufacturing process or added by the consumer at the time of preparation or use. A number of materials which interact with tooth stains and/or staining agents to counteract their effect and/or reduce their coloration as well as substances which interact with teeth to block the interaction of staining agents with teeth are disclosed.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: March 10, 2015
    Inventors: Barry W. Carothers, Donald N. Riggs
  • Publication number: 20150056194
    Abstract: Methods of treating liver disease in a subject, including administering to the subject an effective amount of one or more modified green tea polyphenols to reduce, decrease, limit or prevent one or more symptoms of liver disease relative to an untreated control subject are provided. In a preferred embodiment the one or more modified green tea polyphenols are administered at a dose of 400 mg/kg body weight five times weekly. In some embodiments the disclosed methods further include administering to the subject one or more additional pharmaceutically active agents. In one embodiment the one or more additional pharmaceutically active agents is a chemotherapeutic agent.
    Type: Application
    Filed: August 21, 2014
    Publication date: February 26, 2015
    Inventor: Stephen Hsu
  • Patent number: 8962042
    Abstract: Nutrient compositions comprising botanical extracts and methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed.
    Type: Grant
    Filed: September 28, 2011
    Date of Patent: February 24, 2015
    Inventor: Lisa Geng
  • Publication number: 20150044307
    Abstract: The present invention provides a preparation method of tea water comprising the following steps of: inactivating enzymes of raw tea leaves and juicing the tea leaves to obtain a tea juice; and removing ions of the tea juice obtained from the previous step to obtain tea water. In addition, the present invention provides tea water obtained by removing ions from a tea juice of raw tea leaves of which enzymes are inactivated. Skin-stimulating components are reduced in the tea water.
    Type: Application
    Filed: September 29, 2014
    Publication date: February 12, 2015
    Inventors: Chan S. Rha, Yu J. Oh, Jin O. Chung, Se J. Yoo, Sang J. Lee
  • Publication number: 20150044306
    Abstract: A process for fractionating a plant material to provide isolated extractives, the process includes pretreating the plant material to provide a fluidized plant material, subjecting the pretreated fluidized plant material to high frequency pulses and shear forces without denaturing bioactive aspects of one or more components of the plant material to provide a first liquid fraction having extractives to be isolated and a first fractionated plant material, separating the first liquid fraction having extractives from the first fractionated plant material, and isolating extractives from the first liquid fraction.
    Type: Application
    Filed: August 8, 2014
    Publication date: February 12, 2015
    Inventors: Melvin Mitchell, James Etson Brandenburg, JR.
  • Publication number: 20150044174
    Abstract: The present invention relates to a composition for promoting eye health in a companion animal. The composition comprising: at least one polyphenol selected from the group consisting of rosemary, rosemary extract, coffeic acid, coffee extract, turmeric extract, cucurmin, blueberry extract, grapeseed extract, rosemarinic acid, tea extract, and mixtures thereof.
    Type: Application
    Filed: October 22, 2014
    Publication date: February 12, 2015
    Applicant: THE IAMS COMPANY
    Inventors: Jin Zhang, Michael Griffin Hayek
  • Publication number: 20150037389
    Abstract: The present invention relates to an edible product, which comprises a fibrous plant product and a plant extract applied thereto. Further, the invention relates to a corresponding method for producing said edible product and its use in at least one of food, food supplement, medicinal, cosmetic, well-being, nutraceutical or phytotherapeutical applications. The plants used may be all plants comprising one or more substances of interest for an edible product.
    Type: Application
    Filed: July 31, 2014
    Publication date: February 5, 2015
    Inventors: Philippe Ragot, Esther Pons, Bernard Mompon, Cedric Rousseau
  • Patent number: 8940343
    Abstract: The present invention relates to a personal care composition. More particularly the present invention relates to stabilization of UVA sunscreen dibenzoylmethane derivatives or even more particularly Parsol 1789™ (4-t-butyl-4?-methoxydibenzoylmethane) in personal care compositions. It is an object of the present invention to provide a personal care composition with relatively long photoprotection efficiency. It is another object of the present invention to stabilize Parsol 1789 by use of a natural substance or materials derived from plants. Surprisingly the present inventors have found that theaflavin or black tea extract having high levels of theaflavin, can act as a photostabilizer for dibenzoylmethane derivatives or Parsol-1789™.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: January 27, 2015
    Assignee: Conopco Inc.
    Inventors: Mohan Vijaykumar Chavan, Deepak Ramachandra Mhasavade, Ashish Anant Vaidya
  • Publication number: 20150024041
    Abstract: The current invention is a supplement made from a combination of herbs, vitamins, amino acids which in the preferred embodiment is a 100% vegetarian liquid capsules that are ingested allow for rapid absorption. The components of the supplement can be mint or menthol such as peppermint or spearmint, Methyl B12 or B12, Niacin, Guarana, Dimethylaminoethanol, Acetyl-L-carnitine or ALCAR, Ocimum tenuiflorum, one or more teas such as green tea, white tea or black tea, Ginkgo, Rhodiola rosea, phosphatidylserine, Tyrosine, L-Alpha Glycerylphosphorylcholine, Citicoline (INN), Huperzine A, and Vinpocetine.
    Type: Application
    Filed: October 6, 2014
    Publication date: January 22, 2015
    Inventor: Shaahin Cheyene
  • Patent number: 8920854
    Abstract: Disclosed herein are oral care compositions for promoting salivary flow. Thus, also disclosed are methods of treating and preventing xerostomia. The oral care compositions can contain all-natural ingredients, including, for example, green tea polyphenols and jaborandi extract.
    Type: Grant
    Filed: February 22, 2010
    Date of Patent: December 30, 2014
    Assignee: Georgia Regents Research Institute
    Inventor: Stephen D. Hsu
  • Patent number: 8916211
    Abstract: A method and composition for preventing and treating avian influenza utilizes an effective quantity of polyphenolic(s) and its derivatives in combination with a carrier. The anti-avian influenza ingredient having a composition selected from the group consisting of theaflavin, theaflavin-3,3?-digallate, theaflavin-3-monogallate, theaflavin-3 gallate, theaflavin-3?-gallate, thearubigin, gallic acid, tannic acid, (?)-epigallocatechin gallate (EGCG), (?)epigallocatechin (EGC), (+)-epicatechin (EC), (?)-gallocatechin gallate (GCG), and catechin.
    Type: Grant
    Filed: May 22, 2013
    Date of Patent: December 23, 2014
    Assignee: Abattis Bioceuticals Corp.
    Inventors: Charles Hensley, Sung Pyo
  • Publication number: 20140348883
    Abstract: A nutritional supplement composition enhances cognitive function and includes huperzine A, vinpocetine, acetyl-L-carnitine, and rhodiola. The composition is formulated for oral administration. The huperzine A, vinpocetine, acetyl-L-carnitine, and rhodiola are in a ratio a:b:c:d: respectively such that a as the huperzine A is between about 0.8 and 1.2, b as vinpocetine is between about 80 and 120, c as rhodiola is about 1,600 and 2,400, and d as the acetyl-L-carnitine is between about 8,000 and 12,000.
    Type: Application
    Filed: August 7, 2014
    Publication date: November 27, 2014
    Inventor: JOSH REYNOLDS
  • Patent number: 8895084
    Abstract: An oral composition for at least one or treating and inhibiting an oral inflammatory condition comprising: a Camellia extract including at least about 30% epigallocatechin gallate, at least about 50% total catechins, and at least about 60% total polyphenols; and a substantially water insoluble non-cationic anti-bacterial agent.
    Type: Grant
    Filed: October 24, 2005
    Date of Patent: November 25, 2014
    Assignee: Colgate-Palmolive Company
    Inventors: Cortney L. Worrell, Harsh M. Trivedi, Kimberlee Panaligan, Tao Xu
  • Publication number: 20140302178
    Abstract: Gene-Eden-VIR is a natural product that decreases the severity, duration, and frequency of symptoms during a viral infection, including infections with the Human Papillomavirus (HPV), Epstein Barr Virus (EBV), Herpes Simplex Virus (HSV), Human Cytomegalovirus (HCMV), and Hepatitis C Virus (HCV).
    Type: Application
    Filed: April 4, 2013
    Publication date: October 9, 2014
    Inventor: Hanan Polansky
  • Patent number: 8852655
    Abstract: Disclosed herein is a cosmetic composition which can inhibit skin aging resulting from external harmful environmental factors such as UV light and environmental pollution, which promote aging. More specifically, disclosed is a cosmetic composition, which contains green tea polysaccharide and Tricholoma matsutake extract and shows an excellent anti-aging effect by inhibiting skin inflammatory and oxidative processes.
    Type: Grant
    Filed: February 4, 2010
    Date of Patent: October 7, 2014
    Assignee: Amorepacific Corporation
    Inventors: Chan Koo Kang, Sung A Cho, Ji Hyun Kim, Hui Kyoung Chang, Nok Hyun Park, Jun Cheol Cho
  • Publication number: 20140294987
    Abstract: A composition of matter comprises a shelf stable, super critical, CO2 fluid extracted seed oil derived from a cracked biomass of perilla frutescens, the seed oil comprising from about 60 to about 95 percent w/w of PUFAs in a ratio of from about 4:1 to about 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and a mixture of selected antioxidants.
    Type: Application
    Filed: June 11, 2014
    Publication date: October 2, 2014
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck, Uy Nguyen
  • Patent number: 8846053
    Abstract: The present invention is embodied by a composition capable inducing weight loss in a patient in need thereof.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: September 30, 2014
    Assignee: SDG, Inc.
    Inventors: W. Blair Geho, John R. Lau
  • Publication number: 20140287071
    Abstract: Veterinary supplements comprising one or more Nrf2-activating agents are disclosed. The veterinary supplements may further comprise omega-3 fatty acids and collagen. The veterinary supplements are effective for treating, inhibiting, reducing and/or preventing oxidative stress.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 25, 2014
    Applicant: LifeVantage Corporation
    Inventor: William M. Barnett, III
  • Publication number: 20140286990
    Abstract: A mud mask with real leaves is described. The mud mask is made by separating a leaf batch into a first sub-batch, a second sub-batch, and a third sub-batch. The first sub-batch is ground into a fine powder, while the second sub-batch remains as whole leaves and the third sub-hatch is chopped into partially chopped leaves. The fine powder and whole leaves are added to hot water for a period of time to form a brewed tea. Thereafter, the partially chopped leaves and mud components are added to the brewed tea to form a mud solution, which is mixed to form the mud product. The mud product is packaged and allowed to marinate, which allows the leaves to begin releasing their nutrients and antioxidants into the mud formula, after which the mud mask includes atypical and unusually high levels of nutrients, antioxidants and caffeine.
    Type: Application
    Filed: June 3, 2014
    Publication date: September 25, 2014
    Applicant: Glamglow, Inc.
    Inventors: Shannon Beth Dellimore, Glenn Dellimore
  • Publication number: 20140271944
    Abstract: An antioxidant-promoting composition that increases antioxidant defense potential in a subject is disclosed. The composition contains Bacopa monniera extract comprising a Bacopa monniera active ingredient; a Silybum marianum (milk thistle) extract comprising a Silybum marianum active ingredient; a Withania somnifera (ashwagandha) extract comprising a Withania somnifera active ingredient; a Camellia sinensis (green tea) extract comprising a Camellia sinensis active ingredient; a Curcuma longa (turmeric) extract comprising at least one Curcuma longa active ingredient, and optionally a Centella asiatica (Gotu kola) extract; a Ginko biloba extract; an Aloe vera extract; and N-acetyl cysteine. The process for quantifying Nrf2 transcription factor activating potential of the botanical extracts comprising the botanical active ingredients is described.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Applicant: LIFELINE NUTRACEUTICALS
    Inventors: Joe Milton McCord, William J. Driscoll
  • Publication number: 20140255512
    Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.
    Type: Application
    Filed: May 23, 2014
    Publication date: September 11, 2014
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Franco GAETANI, Ashraf VIRMANI
  • Publication number: 20140255485
    Abstract: The present invention relates to collagen hydrolysate and the use thereof for treating and/or preventing cellulite.
    Type: Application
    Filed: May 20, 2014
    Publication date: September 11, 2014
    Applicant: GELITA AG
    Inventors: Hans-Ulrich FRECH, Steffen OESSER, Stephan HAUSMANNS
  • Patent number: 8828412
    Abstract: Disclosed herein are stable oil-in-water emulsion ophthalmic topical liquid compositions having an average particle size less than 1 ?m including at least one plant-derived oil other than castor oil wherein the oil comprises only aliphatic side chains free of polar pendent groups. The oil-in-water emulsion ophthalmic topical liquid compositions also include a hydrophilic surfactant having an HLB value between approximately 10 and 14, a vegetable oil-derived hydrophobic non-co-block surfactant having unsaturated side chains that contain less than four oxygen atoms having an HLB value between approximately 4 and 6 and is a liquid at room temperature. The oil-in-water emulsion ophthalmic topical liquid compositions disclosed herein can further include an amount of cyclosporine A or polyphenol in an amount effective to relieve dry eye symptoms.
    Type: Grant
    Filed: June 2, 2010
    Date of Patent: September 9, 2014
    Assignee: Abbott Medical Optics Inc.
    Inventors: Zhi-Jian Yu, Stanley W. Huth, Stephen J. Demichele
  • Publication number: 20140242009
    Abstract: The present invention relates to isolated bioactive compositions containing bioactive fractions derived from Theacea plants. The present invention also relates to bioactive topical formulations containing the bioactive compositions. The present invention further relates to methods of using the bioactive compositions of the present invention, including, for example, methods for inhibiting inflammatory activity in skin tissue of a mammal, for protecting skin tissue of a mammal from ultraviolet light-induced damage, and for normalizing skin disorders in skin tissue of a mammal. The present invention also relates to methods for isolating bioactive fractions derived from cell juice or a cell walls component a Theacea plant.
    Type: Application
    Filed: May 6, 2014
    Publication date: August 28, 2014
    Applicant: AKZO NOBEL SURFACE CHEMISTRY LLC
    Inventor: Michael KOGANOV
  • Patent number: 8815310
    Abstract: This invention relates to orally ingested compositions for boosting metabolic rate and reducing or controlling levels of cholesterol and triglycerides and improving cardiovascular function, thus preferably assisting with weight loss and promoting cardiovascular health when administered to mammals, including humans.
    Type: Grant
    Filed: January 10, 2012
    Date of Patent: August 26, 2014
    Inventors: Morteza Naghavi, Albert Andrew Yen, Mortaza Mark Naghavi, Mojtaba Frank Naghavi, Susan Michelle Splering
  • Publication number: 20140234284
    Abstract: The present invention relates to an isocyanate-free multi-component system, in particular for medical uses such as foamable wound coverings, with at least two separate components, wherein the first component comprises at least one alkoxysilane-terminated prepolymer and the second component comprises an aqueous component, wherein the aqueous component is a polyurethane dispersion.
    Type: Application
    Filed: September 24, 2012
    Publication date: August 21, 2014
    Applicant: Bayer Intellectual Property GmbH
    Inventors: Jan Schönberger, Sebastian Dörr
  • Patent number: 8808770
    Abstract: The present invention relates to a composition and a kit for the protection, treatment and repair of cartilage in humans and animal joints. The composition or kit contains a combination of unsaponifiable lipids together with one or more of polyphenols and/or catechins. Preferably, the composition or kit contains avocado:soybean unsaponifiables (ASU) and green tea.
    Type: Grant
    Filed: May 14, 2010
    Date of Patent: August 19, 2014
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Todd R. Henderson, Louis Lippiello, Charles Filburn, David Griffin
  • Patent number: 8808757
    Abstract: An herbal ointment. The herbal ointment may include about 45 weight percent of herb-infused oil, water or alcohol, or any desired combination thereof, about 30 weight percent purified water, about 10 weight percent emulsifier wax, about 5 weight percent menthol, about 3 weight percent dimethyl isosorbide, about 2 weight percent glycerin, about 2 weight percent hydrogenated methyl abietate, about 0.5 weight percent lonicera caprifolium and lonicera japanica extract, about 0.5 weight percent tocopherol, about 0.35 weight percent vanillyl butyl ether, about 0.35 weight percent xanthan gum, about 0.3 weight percent citric acid 50% aqueous solution, and about 0.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: August 19, 2014
    Assignee: Jaxsen's LLC
    Inventors: Michael J. Urschel, Tara L. Urschel, Kraig D. Moore
  • Patent number: 8808761
    Abstract: The present invention relates to a composition of skin external application comprising rose extracts and epigallocatechin gallate (EGCG) as effective ingredients, more particularly to a composition of skin external application that contains rose extracts and EGCG, thereby promoting the synthesis of collagen fiber to promote superior skin elasticity and skin wrinkle improvement with long-lasting effect.
    Type: Grant
    Filed: November 1, 2005
    Date of Patent: August 19, 2014
    Assignee: Amorepacific Corporation
    Inventors: Hwa Jun Lee, Jun Cheol Cho, Sang Hoon Han
  • Publication number: 20140227214
    Abstract: A carotenoid substance called zeaxanthin, when ingested orally at suitable dosages such as 30 to 100 mg/day for a span of 1 to 2 weeks, can provide effective protection against sunburns, and can give skin a darker tint that emulates a healthy suntan. In tests involving adults, it was found that zeaxanthin dosages of 30 to about 80 mg per day were sufficient to induce: (i) a mild but noticeable tinting, shading, or darkening of skin color, comparable to a mild suntan; (ii) a substantial increase in the person's ability to withstand elevated levels of sun or UV exposure without any subsequent pain or discomfort, and without the subsequent peeling and flaking that characterizes sunburns; and, (iii) an increased ability of reddened and sunburned skin to convert into intact skin that looks browned and healthily tanned.
    Type: Application
    Filed: April 22, 2014
    Publication date: August 14, 2014
    Applicant: ZeaVision, LLC
    Inventors: Dennis L. Gierhart, Joseph A. Fox
  • Publication number: 20140227363
    Abstract: Described herein are various natural ingredients for skin-related applications. Individual compounds provide beneficial effects for improved collagen production, fibroblast proliferation, antioxidant protection and free radical inhibition. Combinations of these individual compounds exhibit synergistic effects, leading to dramatic improvements in skin moisture levels, wrinkle reduction, and elasticity. Various examples of combined ingredients are provided, which can be applied in methods related to conditioning the skin, and in cosmetic formulations for improved aesthetic appearance.
    Type: Application
    Filed: August 3, 2012
    Publication date: August 14, 2014
    Applicant: STEMTECH INTERNATIONAL, INC.
    Inventors: Christian Drapeau, Shakahn Kukulcan, Gitte S. Jensen
  • Patent number: 8802163
    Abstract: A natural soap is made using a herbal medicine decoction. The natural soap includes herbs including lotus roots, lotus leaves, red ginseng, Hippophae rhamnoides leaves and trunk, persimmon leaves, thuja orientalis, ginger, rosemary, black beans, black sesame, aloe, mulberry leaves, Orostachys japonicus, Angelica gigas, green tea, pine needles, mint, pleuropterus multiflorus, blueberry, and Acorus gramineus. A ripening device ripens the herbs in temperatures of 65 to 95° C. for 3 to 15 days, distilled water or soft water is poured onto the herbs, and the herbs mixed with the water are decocted by a decoction maker.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: August 12, 2014
    Inventor: Eun Joo Ko
  • Patent number: 8784909
    Abstract: A mud mask with real green tea leaves is described. The mud mask is made by separating a real green tea leaf batch into a first sub-batch, a second sub-batch, and a third sub-batch. The first sub-batch is ground into a fine powder, while the second sub-batch remains as whole leaves and the third sub-batch is chopped into partially chopped leaves. The fine powder and whole leaves are added to hot water for a period of time to form a brewed tea. Thereafter, the partially chopped leaves and mud components are added to the brewed tea to form a mud solution, which is mixed to form the mud product. The mud product is packaged and allowed to marinate, which allows the leaves to begin releasing their nutrients and antioxidants into the mud formula, after which the mud mask includes atypical and unusually high levels of nutrients, antioxidants and caffeine.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: July 22, 2014
    Assignee: Glamglow, Inc.
    Inventors: Shannon Beth Dellimore, Glenn Dellimore
  • Patent number: 8778420
    Abstract: This invention relates to compositions and applications for a topical skin care composition that includes from about 52 wt % to about 90 wt % Camellia sinensis (green tea) extract; from about 0.5 wt % to about 15 wt % Calendula officinalis extract; from about 0.5 wt % to about 10 wt % Trifolium pratense (red clover blossom) extract; from about 0.1 wt % to about 5 wt % Lavandula angustifolia essential oil in coco-caprylate/caprate; from about 0.5 wt % to about 5 wt % glycerin; an emulsifier component in an amount from about 2 wt % to about 10 wt %; and a preservative component in an amount from about 0.5 wt % to about 3 wt %, wherein the amounts are by total weight of the composition.
    Type: Grant
    Filed: February 26, 2013
    Date of Patent: July 15, 2014
    Inventor: Gary Boyt
  • Publication number: 20140193480
    Abstract: Disclosed are pharmaceutical compositions and topical formulations thereof that include multiple, phytochemically-active, nutraceutical compounds, and that possess potent anti-inflammatory and extracellular matrix-stabilizing properties both in vitro and in vivo. Also disclosed are prophylactic and therapeutic methods, as well as dosing regimens and medicaments for use in preventing chronic disease, for treating acute or long-term inflammatory-mediated conditions in affected or at-risk subjects, and for stabilizing one or more components of the mammalian extracellular matrix.
    Type: Application
    Filed: October 15, 2013
    Publication date: July 10, 2014
    Applicant: MD MATRIX HEALTH LLC DBA MD MATRIX HEALTH INC.
    Inventors: Joseph F. McWherter, Uzzi Reiss
  • Publication number: 20140193345
    Abstract: The present invention provides therapeutic compositions comprising extracts of the plant species Echinacea purpurea and Sambucus nigra and the extract(s) of at least one further plant selected from the group consisting of Hypericum perforatum, Commiphora molmol and Centella asiatica. The compositions of the invention are of particular utility in the management of inflammatory mucosal diseases of both viral and non-viral origin.
    Type: Application
    Filed: March 12, 2014
    Publication date: July 10, 2014
    Applicant: IZUN PHARMACEUTICALS CORPORATION
    Inventors: William Z. LEVINE, Aron J. SAFFER, Mina FRAN
  • Publication number: 20140186315
    Abstract: The present invention provides a cosmetic composition containing one or more selected from a group consisting of green tea saponin and green tea polyphenol as active ingredients. The cosmetic composition of the invention is very safe to the skin and can greatly enhance biological mechanisms in the skin, and thus can serve as an anti-aging cosmetic composition.
    Type: Application
    Filed: August 20, 2012
    Publication date: July 3, 2014
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Hyun Seo Kang, Seung Hyun Kang, Ji Hyun Kim, Ji Seong Kim, Yong Joo Na, Byung Geun Chae, Sang Hoon Han
  • Publication number: 20140186278
    Abstract: An anhydrous multiphase gel system consisting of an outer lipid matrix and an inner phase gelled by means of a polymer is described, which can be obtained by a) Melting the lipid phase with the formation of a liquid lipid phase, b) Mixing and homogenizing polymers or polymer blends capable of swelling with the formation of a polymer phase to be dispersed, c) Combining the polymer phase with the liquid lipid phase and homogenizing the phases, and d) Cold stirring the phase mixture until a solid gel-like mixed structure of the entire system is formed. The anhydrous multiphase gel system is particularly suitable for taking up difficulty soluble active substances in high concentration and for providing topical and transdermal applications. The described system is called an EDRS, “Entrapped Drug Reservoir System”.
    Type: Application
    Filed: September 19, 2013
    Publication date: July 3, 2014
    Inventor: Patrick Franke
  • Patent number: 8765193
    Abstract: Provided is a method for protecting an individual against radiation-induced internal damage that comprises administering an effective amount of an oral composition. The oral composition comprises a mixture of Gynostemma pentaphyllum, Crataegus pinnatifida (hawthorn), and Camellia sinensis (green tea) to an individual so that radiation-induced internal damage will be prevented or ameliorated.
    Type: Grant
    Filed: December 6, 2012
    Date of Patent: July 1, 2014
    Assignee: Santé International, Inc.
    Inventor: Arthur H. K. Djang
  • Patent number: 8758835
    Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: June 24, 2014
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Franco Gaetani, Ashraf Virmani
  • Publication number: 20140170246
    Abstract: A topical composition having at least one active agent selected from a depilatory agent(s), an agent(s) for preventing or reducing the growth or re-growth of hair and an agent(s) for preventing or reducing in-growing hair, and a gas, wherein the at least one active agent and gas are dispersed in a cosmetically acceptable medium.
    Type: Application
    Filed: February 20, 2014
    Publication date: June 19, 2014
    Inventors: Magali Bertrand, Philippe Henriat
  • Publication number: 20140161913
    Abstract: The present invention relates to a method for promoting eye health by administering to a companion animal a composition comprising at least one polyphenol selected from the group consisting of rosemary, rosemary extract, coffeic acid, coffee extract, turmeric extract, cucurmin, blueberry extract, grapeseed extract, rosemarinic acid, tea extract, and mixtures thereof.
    Type: Application
    Filed: February 18, 2014
    Publication date: June 12, 2014
    Applicant: The IAMS Company
    Inventors: Jin Zhang, Michael Griffin Hayek
  • Publication number: 20140161855
    Abstract: A cosmetic including two different systems for procurement of actives in the human skin and enhancing the collagen I synthesis. The cosmetic with enhanced collagen I synthesis can include 0.001 to 2% by weight, related to the total weight of the cosmetic, of a first retinol-containing system including retinol encapsulated in a chitosan and carboxymethyl cellulose shell, 0.001 to 3.5% by weight, related to the total weight of the cosmetic, of a second retinol-containing system including cationic liposomes composed of phospholipids and with a quaternary fatty acid monoamine with C21-C23 alkyl residue and the difference to 100% by weight of cosmetic subsidiaries. Very small amounts of retinol in combination with both transport systems show a remarkable effect on the synthesis of collagen I in comparison with one or more other known combinations of retinol derivatives or encapsulated systems.
    Type: Application
    Filed: July 13, 2012
    Publication date: June 12, 2014
    Applicant: Monsanto Technology LLC a corporation
    Inventors: Olivier Doucet, Muriel Pujos, Cécile Robert, Dorothée Bernini
  • Publication number: 20140147524
    Abstract: Truely Re'Vived is a Natural, holistic product line that allows an alternative choice for a natural way of life. By combining key natural ingredients Truely Re' Vived sets forth the natural healing processes (faster than the normal pace) without the use of chemicals. Truly Re'Vived's has a variety of phenomenal products: “Earth” was created to heal a variety of skin disorders. “Wind” was created to revive, and restore the balance of all grades of hair, giving it life. “Sun” was created to moisturize and heal lip irritancies. “Moon” is a Body Lotion that revitalizes the skins for a healthy appearance. Truely Re'Vived is the alternative to medicine and a true gift that the worlds needs.
    Type: Application
    Filed: November 24, 2012
    Publication date: May 29, 2014
    Inventor: Seanterel Latrice Darby
  • Patent number: 8734867
    Abstract: The present invention is directed to a method and a composition for producing and using a plant-based biocidal solution. The plant-based biocidal solution contains a bioactive material and a plant-based substance formed from the cellular material of a plant. The plant-based substance is capable of binding to the bioactive material. In some embodiments, the bioactive material is hydrogen peroxide. The hydrogen peroxide can be added exogenously or generated endogenously. In accordance with further embodiments, the plant-based biocidal solution can be applied to a target, thereby impairing the target. In some embodiments, the target can be a pathogen. In accordance with another embodiment, the plant-based substance of the plant-based biocidal solution can form a microscopic cluster, a complex, or an aggregate for providing sufficient bioactive material to overcome the defense mechanism of the target.
    Type: Grant
    Filed: December 23, 2008
    Date of Patent: May 27, 2014
    Assignee: Liveleaf, Inc.
    Inventors: Alexander L. Huang, Gin Wu
  • Patent number: 8728547
    Abstract: The invention provides methods for increasing resting metabolic rate, reducing waist circumference, and weight control by administering a composition comprising dietary fiber, phenylalanine, tyrosine, tea blend, caffeine, and Lycium plants or Lycium plant extract preparations to the subject. The invention also provides a food or dietary supplement formulation which contains dietary fiber, phenylalanine, tyrosine, tea blend, caffeine, and Lycium plants or Lycium plant extract preparations.
    Type: Grant
    Filed: February 5, 2009
    Date of Patent: May 20, 2014
    Assignee: Freelife International, Inc.
    Inventors: Harunobu Amagase, Richard Handel
  • Publication number: 20140134222
    Abstract: The present invention provides a composition comprising an effective amount of benfotiamine and an effective amount of pyridoxamine in a suitable vehicle for topical application. The present compositions are useful in improving the appearance of aged skin characterized by wrinkles, loss of elasticity, and hyperpigmentation caused by chronoaging and/or photoaging of skin, by inhibiting particularly skin damage resulting from reactive carbonyl species (RCS), glycation of skin proteins, formation of advanced glycation endproducts (AGEs) and formation of advanced lipoxidation endproducts (ALEs).
    Type: Application
    Filed: January 17, 2014
    Publication date: May 15, 2014
    Applicant: Tracie Martyn International, Inc.
    Inventor: Marius Morariu
  • Patent number: 8722116
    Abstract: The present invention is directed to a method and a composition for producing and using a plant-based biocidal solution. The plant-based biocidal solution contains a bioactive material and a plant-based substance formed from the cellular material of a plant. The plant-based substance is capable of binding to the bioactive material. In some embodiments, the bioactive material is hydrogen peroxide. The hydrogen peroxide can be added exogenously or generated endogenously. In accordance with further embodiments, the plant-based biocidal solution can be applied to a target, thereby impairing the target. In some embodiments, the target can be a pathogen. In accordance with another embodiment, the plant-based substance of the plant-based biocidal solution can form a microscopic cluster, a complex, or an aggregate for providing sufficient bioactive material to overcome the defense mechanism of the target.
    Type: Grant
    Filed: August 25, 2010
    Date of Patent: May 13, 2014
    Assignee: Liveleaf, Inc.
    Inventors: Alexander L. Huang, Gin Wu
  • Publication number: 20140127286
    Abstract: The invention refers to a cosmetic composition for increasing collagen synthesis in skin cells comprising 0.001-0.5 wt % of a Phaeodactylum tricornutum extract, 0.00001-2.0 wt % of Dimer Tripeptide-43 or Hydrolyzed Rice Protein, and cosmetic auxiliaries. The cosmetic composition comprising the combination of both components has an synergistic effect on collagen I synthesis in skin cells and has a booster effect to other substances which are known to have an enhancing effect to collagen I synthesis.
    Type: Application
    Filed: April 18, 2012
    Publication date: May 8, 2014
    Inventors: Olivier Doucet, Muriel Pujos, Cécile Robert, Dorothée Bernini